Skip to main content
Livermore
Livermore
ZHEN

Relay Therapeutics, Inc.

RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001812364

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Relay Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of RLAY: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1792195+18
Shares126.8M10.6M163.4M+47.2M (+40.6%)
Value$826.8M$69.1M$1.16B+$399.0M (+52.7%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (46)

Institutions that held Relay Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to RLAY in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.11,742,147$83.1M0.00%
Tang Capital Management LLC3,568,058$25.3M1.80%
Eventide Asset Management, LLC2,682,083$19.0M0.33%
EcoR1 Capital, LLC2,500,000$17.7M0.61%
Adage Capital Partners GP, L.L.C.1,650,000$11.7M0.02%
First Light Asset Management, LLC1,542,406$10.9M0.91%
Point72 Asset Management, L.P.1,349,400$9.55M0.03%
First Turn Management, LLC1,226,354$8.68M1.37%
Foresite Capital Management IV, LLC1,000,000$7.08M4.63%
Sio Capital Management, LLC945,839$6.70M3.00%
Soleus Capital Management, L.P.910,000$6.44M0.54%
Ikarian Capital, LLC693,350$4.91M1.52%
Ally Bridge Group (NY) LLC626,058$4.43M2.37%
Silverarc Capital Management, LLC419,242$2.97M0.67%
Exome Asset Management LLC414,629$2.94M1.98%
Nicholas Investment Partners, LP376,014$2.66M0.24%
Cubist Systematic Strategies, LLC359,332$2.54M0.04%
Maven Securities LTD337,426$2.39M0.27%
Monashee Investment Management LLC320,000$2.27M0.25%
Boothbay Fund Management, LLC208,708$1.48M0.05%
UBS Oconnor LLC112,048$793.3K0.02%
Prelude Capital Management, LLC109,912$778.2K0.06%
Jump Financial, LLC101,975$722.0K0.01%
SG Americas Securities, LLC55,084$390.0K0.00%
Y-Intercept (Hong Kong) Ltd51,856$367.1K0.02%
Virtu Financial LLC47,010$333.0K0.02%
Legato Capital Management LLC45,302$320.7K0.04%
Nebula Research & Development LLC39,584$280.3K0.03%
Intech Investment Management LLC36,176$256.1K0.00%
Quarry LP36,000$254.9K0.08%
Valence8 US LP26,200$185.5K0.08%
Point72 (DIFC) Ltd18,891$133.7K0.01%
Scientech Research LLC18,727$132.6K0.03%
Mesirow Financial Investment Management, Inc.14,536$102.9K0.00%
Aster Capital Management (DIFC) Ltd13,324$94.3K0.02%
Values First Advisors, Inc.10,579$74.9K0.04%
Portland Investment Counsel Inc.10,000$70.8K0.03%
Point72 Asia (Singapore) Pte. Ltd.8,894$63.0K0.01%
Shell Asset Management Co7,160$51.0K0.00%
Caption Management, LLC7,000$49.6K0.01%
Farther Finance Advisors, LLC2,187$15.5K0.00%
Quest Partners LLC1,770$12.5K0.00%
Webster Bank, N. A.1,000$7.08K0.00%
Sterling Capital Management LLC351$2.48K0.00%
Headlands Technologies LLC74$5240.00%
Capital Performance Advisors LLP11$780.00%

Sold out (28)

Institutions that held Relay Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of RLAY in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Logos Global Management LP1,300,000$8.48M
Integral Health Asset Management, LLC750,000$4.89M
Driehaus Capital Management LLC616,220$4.02M
Prosight Management, LP385,000$2.51M
Baillie Gifford & Co284,058$1.85M
Qube Research & Technologies Ltd156,254$1.02M
Schroder Investment Management Group153,769$1.00M
Caxton Associates LP107,568$701.3K
Schonfeld Strategic Advisors LLC105,518$688.0K
Man Group plc101,365$660.9K
Wellington Management Group LLP71,913$468.9K
Balyasny Asset Management LLC65,989$430.2K
Royce & Associates LP48,381$315.4K
Deerfield Management Company, L.P. (Series C)46,702$304.5K
Capstone Investment Advisors, LLC44,511$290.2K
Bayesian Capital Management, LP43,900$286.2K
Pennant Investors, LP42,400$276.4K
Principal Financial Group Inc14,580$95.1K
Vontobel Holding Ltd.14,432$94.1K
Catalyst Funds Management Pty Ltd2,500$16.3K
Pacer Advisors, Inc.1,103$7.19K
Lindbrook Capital, LLC645$4.21K
Wetzel Investment Advisors, Inc.500$4.15K
Signaturefd, LLC624$4.07K
Versant Capital Management, Inc309$2.02K
Ronald Blue Trust, Inc.52$432
Parallel Advisors, LLC14$91
TFC Financial Management1$7

Not filed for Q3 2024 yet (2)

Institutions that held Relay Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RLAY in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.10,542,667$68.7M
Susquehanna Fundamental Investments, LLC53,442$348.4K